Search
USFDA Guidance: Continuous Glucose Monitoring Data in Clinical Trials and Postapproval Pregnancy Safety Studies
The U.S. Food and Drug Administration (FDA) continues to modernize clinical research and postmarketing safety monitoring through new guidance documents focused on digital health technologies and real-world safety evidence. In May 2026, FDA published two important guidance documents: Submitting Continuous Glucose Monitoring Data in Clinical Trials Postapproval Pregnancy Safety Studies Guidance on Continuous Glucose Monitoring (CGM) Data in Clinical Trials What is Continuous Gl
Sharan Murugan
6 hours ago3 min read